Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Holiland Enterprise Investment Management is the primary investment and corporate management vehicle for the Holiland (Haolilai) Group, China's leading bakery and food service conglomerate. While the group is primarily recognized for its extensive chain of high-end bakeries and food products, it maintains a significant strategic interest in the healthcare and life sciences sectors, evidenced by a vast portfolio of intellectual property. The company holds trademarks and patents for medical devices, including ocular implants and surgical instruments, as well as pharmaceutical research services and biotechnology consulting. Additionally, Holiland has explored the functional food market through partnerships for probiotic integration in its products. Led by founder Luo Hong, the firm manages the group's diverse business operations and strategic investments across China. The company's extensive registration of healthcare-related trademarks suggests a long-term strategy for diversification into the wellness and medical technology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holiland Enterprise Investment Management.